Abstract P4-07-05: Matched germline and tumor profiling in male breast cancer for the discovery of molecular subtypes with clinical relevance
Veronica Zelli(University of L'Aquila), Laura Ottini(Mount Sinai Hospital), Ines Zanna(Piedmont Reference Center for Epidemiology and Cancer Prevention), Agostino Bucalo(Sapienza University of Rome), Laura Cortesi(Azienda Ospedaliero-Universitaria di Modena), Domenico Palli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Valentina Silvestri(Cancer Research UK Cambridge Center), Virginia Valentini(Sapienza University of Rome), Daniele Calistri(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Stephen B. Fox(Peter MacCallum Cancer Centre), Giuseppe Giannini(Istituto Pasteur), Maria Grazia Tibiletti(University of Insubria), Piera Rizzolo(Sapienza University of Rome)
Cited by 1
Related Papers
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
|JNCI Journal of the National Cancer Institute|2005|865
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741